<?xml version="1.0" encoding="UTF-8"?>
<ref id="B19-pharmaceutics-11-00234" class="ref">
 <label class="label">19.</label>
 <element-citation publication-type="journal" class="element-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Saraf</surname>
    <given-names class="given-names">S.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Jain</surname>
    <given-names class="given-names">A.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Hurkat</surname>
    <given-names class="given-names">P.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Jain</surname>
    <given-names class="given-names">S.K.</given-names>
   </name>
  </person-group>
  <article-title class="article-title">Topotecan Liposomes: A Visit from a Molecular to a Therapeutic Platform</article-title>
  <source class="source">Crit. Rev. Ther. Drug Carr. Syst.</source>
  <year class="year">2016</year>
  <volume class="volume">33</volume>
  <fpage class="fpage">401</fpage>
  <lpage class="lpage">432</lpage>
  <pub-id pub-id-type="doi" class="pub-id">10.1615/CritRevTherDrugCarrierSyst.2016015926</pub-id>
 </element-citation>
</ref>
